Cargando…
Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
Autores principales: | Woodfield, Sarah E., Shi, Yan, Patel, Roma H., Chen, Zhenghu, Shah, Aayushi P., Srivastava, Rohit K., Whitlock, Richard S., Ibarra, Aryana M., Larson, Samuel R., Sarabia, Stephen F., Badachhape, Andrew, Starosolski, Zbigniew, Ghaghada, Ketan B., Sumazin, Pavel, Annis, D. Allen, López-Terrada, Dolores, Vasudevan, Sanjeev A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486835/ https://www.ncbi.nlm.nih.gov/pubmed/34599198 http://dx.doi.org/10.1038/s41598-021-98174-7 |
Ejemplares similares
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021) -
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2017) -
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells
por: Woodfield, Sarah E., et al.
Publicado: (2022) -
Indocyanine green fluorescence in second near-infrared (NIR-II) window
por: Starosolski, Zbigniew, et al.
Publicado: (2017) -
Surgical Management of Hepatoblastoma and Recent Advances
por: Yang, Tianyou, et al.
Publicado: (2019)